Regulation of BCRP expression and sulfasalazine pharmacokinetics by the nuclear receptor REV-ERBα

References

• Cal-Kayitmazbatir S, Kulkoyluoglu-Cotul E, Growe J, Selby CP, Rhoades SD, Malik D, Oner H, Asimgil H, Francey LJ, Sancar A, et al. 2021. CRY1-CBS binding regulates circadian clock function and metabolism. Febs J. 288(2):614–639.
   PubMed Web of Science ®Google Scholar
• Carmona-Antonanzas G, Santi M, Migaud H, Vera LM. 2017. Light- and clock-control of genes involved in detoxification. Chronobiol Int. 34(8):1026–1041.
   PubMed Web of Science ®Google Scholar
• Chen L, Manautou JE, Rasmussen TP, Zhong XB. 2019. Development of precision medicine approaches based on inter-individual variability of BCRP/ABCG2. Acta Pharm Sin B. 9(4):659–674.
   PubMed Web of Science ®Google Scholar
• Chen M, Chen M, Lu D, Wang Y, Zhang L, Wang Z, Wu B. 2021. Period 2 regulates CYP2B10 expression and activity in mouse liver. Front Pharmacol. 12:764124.
   PubMed Web of Science ®Google Scholar
• Chen M, Guan B, Xu H, Yu F, Zhang T, Wu B. 2019. The molecular mechanism regulating diurnal rhythm of flavin-containing monooxygenase 5 in mouse liver. Drug Metab Dispos. 47(11):1333–1342.
   PubMed Web of Science ®Google Scholar
• Cho H, Zhao X, Hatori M, Yu RT, Barish GD, Lam MT, Chong LW, DiTacchio L, Atkins AR, Glass CK, et al. 2012. Regulation of circadian behaviour and metabolism by REV-ERB-alpha and REV-ERB-beta. Nature. 485(7396):123–127.
   PubMed Web of Science ®Google Scholar
• Fang B, Lazar MA. 2015. Dissecting the Rev-erbalpha cistrome and the mechanisms controlling circadian transcription in liver. Cold Spring Harb Symp Quant Biol. 80:233–238.
   PubMedGoogle Scholar
• Forman BM, Chen J, Blumberg B, Kliewer SA, Henshaw R, Ong ES, Evans RM. 1994. Cross-talk among ROR alpha 1 and the Rev-erb family of orphan nuclear receptors. J Mol Endocrinolo. 8(9):1253–1261.
   Google Scholar
• Hamaguchi H, Fujimoto K, Kawamoto T, Noshiro M, Maemura K, Takeda N, Nagai R, Furukawa M, Honma S, Honma K, et al. 2004. Expression of the gene for Dec2, a basic helix-loop-helix transcription factor, is regulated by a molecular clock system. Biochem J. 382(Pt 1):43–50.
   PubMedGoogle Scholar
• Hamdan AM, Koyanagi S, Wada E, Kusunose N, Murakami Y, Matsunaga N, Ohdo S. 2012. Intestinal expression of mouse Abcg2/breast cancer resistance protein (BCRP) gene is under control of circadian clock-activating transcription factor-4 pathway. J Biol Chem. 287(21):17224–17231.
   PubMed Web of Science ®Google Scholar
• Harding HP, Lazar MA. 1995. The monomer-binding orphan receptor Rev-Erb represses transcription as a dimer on a novel direct repeat. Mol Cell Biol. 15(9):4791–4802.
   PubMed Web of Science ®Google Scholar
• Huang L, Be X, Tchaparian EH, Colletti AE, Roberts J, Langley M, Ling Y, Wong BK, Jin L. 2012. Deletion of Abcg2 has differential effects on excretion and pharmacokinetics of probe substrates in rats. J Pharmacol Exp Ther. 343(2):316–324.
   PubMed Web of Science ®Google Scholar
• Iwasaki M, Koyanagi S, Suzuki N, Katamune C, Matsunaga N, Watanabe N, Takahashi M, Izumi T, Ohdo S. 2015. Circadian modulation in the intestinal absorption of P-glycoprotein substrates in monkeys. Mol Pharmacol. 88(1):29–37.
   PubMed Web of Science ®Google Scholar
• Jani M, Ambrus C, Magnan R, Jakab KT, Beery E, Zolnerciks JK, Krajcsi P. 2014. Structure and function of BCRP, a broad specificity transporter of xenobiotics and endobiotics. Arch Toxicol. 88(6):1205–1248.
   PubMed Web of Science ®Google Scholar
• Kojetin DJ, Burris TP. 2014. REV-ERB and ROR nuclear receptors as drug targets. Nat Rev Drug Discov. 13(3):197–216.
   PubMed Web of Science ®Google Scholar
• Liu H, Zhu Y, Gao Y, Qi D, Zhao L, Zhao L, Liu C, Tao T, Zhou C, Sun X, et al. 2020. NR1D1 modulates synovial inflammation and bone destruction in rheumatoid arthritis. Cell Death Dis. 11(2):129.
   PubMed Web of Science ®Google Scholar
• Lu D, Wang S, Xie Q, Guo L, Wu B. 2017. Transcriptional Regulation of Human UDP-Glucuronosyltransferase 2B10 by Farnesoid X Receptor in Human Hepatoma HepG2 Cells. Mol Pharm. 14(9):2899–2907.
   PubMedGoogle Scholar
• Lu D, Zhao M, Chen M, Wu B. 2020. Circadian Clock-Controlled Drug Metabolism: implications for Chronotherapeutics. Drug Metab Dispos. 48(5):395–406.
   PubMed Web of Science ®Google Scholar
• Ma L, Huang M, Sun G, Lin Y, Lu D, Wu B. 2022. Puerariae lobatae radix protects against UVB-induced skin aging via antagonism of REV-ERBalpha in mice. Front Pharmacol. 13:1088294.
   PubMed Web of Science ®Google Scholar
• Maliepaard M, Scheffer GL, Faneyte IF, van Gastelen MA, Pijnenborg AC, Schinkel AH, van De Vijver MJ, Scheper RJ, Schellens JH. 2001. Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues. Cancer Res. 61(8):3458–3464.
   PubMed Web of Science ®Google Scholar
• Mao Q, Unadkat JD. 2015. Role of the breast cancer resistance protein (BCRP/ABCG2) in drug transport–an update. Aaps J. 17(1):65–82.
   PubMed Web of Science ®Google Scholar
• Meyer zu Schwabedissen HE, Kroemer HK. 2011. In vitro and in vivo evidence for the importance of breast cancer resistance protein transporters (BCRP/MXR/ABCP/ABCG2). Handb Exp Pharmacol. (201):325–371.
   PubMedGoogle Scholar
• Nakanishi T, Ross DD. 2012. Breast cancer resistance protein (BCRP/ABCG2): its role in multidrug resistance and regulation of its gene expression. Chin J Cancer. 31(2):73–99.
   PubMed Web of Science ®Google Scholar
• Ohno T, Onishi Y, Ishida N. 2007. The negative transcription factor E4BP4 is associated with circadian clock protein PERIOD2. Biochem Biophys Res Commun. 354(4):1010–1015.
   PubMed Web of Science ®Google Scholar
• Plosker GL, Croom KF. 2005. Sulfasalazine: a review of its use in the management of rheumatoid arthritis. Drugs. 65(13):1825–1849.
   PubMed Web of Science ®Google Scholar
• Preitner N, Damiola F, Lopez-Molina L, Zakany J, Duboule D, Albrecht U, Schibler U. 2002. The orphan nuclear receptor REV-ERBalpha controls circadian transcription within the positive limb of the mammalian circadian oscillator. Cell. 110(2):251–260.
   PubMed Web of Science ®Google Scholar
• Solt LA, Wang Y, Banerjee S, Hughes T, Kojetin DJ, Lundasen T, Shin Y, Liu J, Cameron MD, Noel R, et al. 2012. Regulation of circadian behaviour and metabolism by synthetic REV-ERB agonists. Nature. 485(7396):62–68.
   PubMed Web of Science ®Google Scholar
• Stearns AT, Balakrishnan A, Rhoads DB, Ashley SW, Tavakkolizadeh A. 2008. Diurnal rhythmicity in the transcription of jejunal drug transporters. J Pharmacol Sci. 108(1):144–148.
   PubMed Web of Science ®Google Scholar
• Sulli G, Rommel A, Wang X, Kolar MJ, Puca F, Saghatelian A, Plikus MV, Verma IM, Panda S. 2018. Pharmacological activation of REV-ERBs is lethal in cancer and oncogene-induced senescence. Nature. 553(7688):351–355.
   PubMed Web of Science ®Google Scholar
• Sutherland LR, May GR, Shaffer EA. 1993. Sulfasalazine revisited: a meta-analysis of 5-aminosalicylic acid in the treatment of ulcerative colitis. Ann Intern Med. 118(7):540–549.
   PubMed Web of Science ®Google Scholar
• Uriz-Huarte A, Date A, Ang H, Ali S, Brady HJM, Fuchter MJ. 2020. The transcriptional repressor REV-ERB as a novel target for disease. Bioorg Med Chem Lett. 30(17):127395.
   PubMed Web of Science ®Google Scholar
• Urquhart BL, Ware JA, Tirona RG, Ho RH, Leake BF, Schwarz UI, Zaher H, Palandra J, Gregor JC, Dresser GK, et al. 2008. Breast cancer resistance protein (ABCG2) and drug disposition: intestinal expression, polymorphisms and sulfasalazine as an in vivo probe. Pharmacogenet Genomics. 18(5):439–448.
   PubMed Web of Science ®Google Scholar
• Wang S, Li F, Lin Y, Wu B. 2020. Targeting REV-ERBalpha for therapeutic purposes: promises and challenges. Theranostics. 10(9):4168–4182.
   PubMed Web of Science ®Google Scholar
• Wang S, Lin Y, Yuan X, Li F, Guo L, Wu B. 2018. REV-ERBalpha integrates colon clock with experimental colitis through regulation of NF-kappaB/NLRP3 axis. Nat Commun. 9(1):4246.
   PubMedGoogle Scholar
• Wang Y, Wang Z, Wu Z, Chen M, Dong D, Yu P, Lu D, Wu B. 2021. Involvement of REV-ERBalpha dysregulation and ferroptosis in aristolochic acid I-induced renal injury. Biochem Pharmacol. 193:114807.
   PubMed Web of Science ®Google Scholar
• Xu H, Chen M, Yu F, Zhang T, Wu B. 2020. Circadian clock component Rev-erbalpha regulates diurnal rhythm of UDP-Glucuronosyltransferase 1a9 and drug glucuronidation in mice. Drug Metab Dispos. 48(8):681–689.
   PubMed Web of Science ®Google Scholar
• Yu F, Wang Z, Zhang T, Chen X, Xu H, Wang F, Guo L, Chen M, Liu K, Wu B. 2021. Deficiency of intestinal Bmal1 prevents obesity induced by high-fat feeding. Nat Commun. 12(1):5323.
   PubMed Web of Science ®Google Scholar
• Yu F, Zhang T, Zhou C, Xu H, Guo L, Chen M, Wu B. 2019. The circadian clock gene Bmal1 controls intestinal exporter MRP2 and drug disposition. Theranostics. 9(10):2754–2767.
   PubMed Web of Science ®Google Scholar
• Zaher H, Khan AA, Palandra J, Brayman TG, Yu L, Ware JA. 2006. Breast cancer resistance protein (Bcrp/abcg2) is a major determinant of sulfasalazine absorption and elimination in the mouse. Mol Pharm. 3(1):55–61.
   PubMedGoogle Scholar
• Zattoni IF, Delabio LC, Dutra JP, Kita DH, Scheiffer G, Hembecker M, Pereira GDS, Moure VR, Valdameri G. 2022. Targeting breast cancer resistance protein (BCRP/ABCG2): Functional inhibitors and expression modulators. Eur J Med Chem. 237:114346.
   PubMed Web of Science ®Google Scholar
• Zhang L, Zhang F, Xiao Y, Du J, Zhang X, Chen M, Wu B. 2022. The nuclear receptor REV-ERBalpha regulates CYP2E1 expression and acetaminophen hepatotoxicity. Xenobiotica. 52(6):633–643.
   PubMed Web of Science ®Google Scholar
• Zhang T, Guo L, Yu F, Chen M, Wu B. 2019. The nuclear receptor Rev-erbalpha participates in circadian regulation of Ugt2b enzymes in mice. Biochem Pharmacol. 161:89–97.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Fang B, Emmett MJ, Damle M, Sun Z, Feng D, Armour SM, Remsberg JR, Jager J, Soccio RE, et al. 2015. GENE REGULATION. Discrete functions of nuclear receptor Rev-erbalpha couple metabolism to the clock. Science. 348(6242):1488–1492.
   PubMed Web of Science ®Google Scholar
• Zhang YK, Yeager RL, Klaassen CD. 2009. Circadian expression profiles of drug-processing genes and transcription factors in mouse liver. Drug Metab Dispos. 37(1):106–115.
   PubMed Web of Science ®Google Scholar
• Zhao M, Zhao H, Deng J, Guo L, Wu B. 2019. Role of the CLOCK protein in liver detoxification. Br J Pharmacol. 176(24):4639–4652.
   PubMed Web of Science ®Google Scholar
• Zhao M, Zhao H, Lin L, Wang Y, Chen M, Wu B. 2020. Nuclear receptor co-repressor RIP140 regulates diurnal expression of cytochrome P450 2b10 in mouse liver. Xenobiotica. 50(10):1139–1148.
   PubMed Web of Science ®Google Scholar
• Zhou C, Yu F, Zeng P, Zhang T, Huang H, Chen W, Wu B. 2019. Circadian sensitivity to the cardiac glycoside oleandrin is associated with diurnal intestinal P-glycoprotein expression. Biochem Pharmacol. 169:113622.
   PubMed Web of Science ®Google Scholar
• Zhou Z, Lin Y, Gao L, Yang Z, Wang S, Wu B. 2020. Circadian pharmacological effects of berberine on chronic colitis in mice: role of the clock component Rev-erbalpha. Biochem Pharmacol. 172:113773.
   PubMed Web of Science ®Google Scholar